General description
Mercaptopurine is a purine antimetabolite antineoplastic agent used in treatment protocols for various leukaemias and lymphomas.
INN
Mercaptopurine
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1984
(TRS
722)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Added in 2015
(TRS
994)
for
Lymphoid leukaemia, not elsewhere classified
Added in 2015
(TRS
994)
for
Acute myeloid leukaemia with recurrent genetic abnormalities
Removed in 2015
(TRS
994)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Added in 2023
(TRS
1049)
for
Langerhans cell histiocytosis
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Oral > Liquid: 20 mg per mL
- Oral > Solid: 50 mg tablet